Osaic Holdings
VTVT icon

Osaic Holdings’s vTv Therapeutics VTVT Stock Holding History

Osaic Holdings’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.4K Sell
1,020
-99
-9% -$3.43K ﹤0.01% 5665
2026
Q1 		$44.4K Sell
1,119
-1
-0.1% -$36 ﹤0.01% 5309
2025
Q4 		$44.8K Sell
1,120
-500
-31% -$13.9K ﹤0.01% 5306
2025
Q3 		$37.2K Buy
1,620
+1,450
+853% +$25.4K ﹤0.01% 5505
2025
Q2 		$2.55K Buy
170
+18
+12% +$330 ﹤0.01% 6848
2025
Q1 		$2.63K Sell
152
-18
-11% -$301 ﹤0.01% 6486
2024
Q4 		$2.35K Sell
170
-8
-4% -$118 ﹤0.01% 6543
2024
Q3 		$2.41K Buy
178
+8
+5% +$133 ﹤0.01% 6539
2024
Q2 		$3K Buy
170
+20
+13% +$477 ﹤0.01% 6423
2024
Q1 		$3.53K Buy
150
+100
+200% +$1.27K ﹤0.01% 6238
2023
Q4 		$575 Sell
50
-50
-50% -$702 ﹤0.01% 6873
2023
Q3 		$1.91K Buy
100
+48
+92% +$1.17K ﹤0.01% 6643
2023
Q2 		$1.52K Hold
52
– – ﹤0.01% 6753
2023
Q1 		$1.66K Hold
52
– – ﹤0.01% 6793
2022
Q4 		$1K Hold
52
– – ﹤0.01% 6979
2022
Q3 		$2K Hold
52
– – ﹤0.01% 6849
2022
Q2 		$2K Hold
52
– – ﹤0.01% 6945
2022
Q1 		$1K Hold
52
– – ﹤0.01% 7129
2021
Q4 		$2K Hold
52
– – ﹤0.01% 7062
2021
Q3 		$3K Sell
52
-37
-42% -$2.79K ﹤0.01% 6776
2021
Q2 		$8K Buy
89
+39
+78% +$3.95K ﹤0.01% 6218
2021
Q1 		$6K Hold
50
– – ﹤0.01% 6098
2020
Q4 		$4K Hold
50
– – ﹤0.01% 5887
2020
Q3 		$4K Hold
50
– – ﹤0.01% 5666
2020
Q2 		$5K Hold
50
– – ﹤0.01% 5500
2020
Q1 		$4K Buy
+50
New +$4.81K ﹤0.01% 5471

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's VTVT Position: Q2 2026 in Review

Osaic Holdings reduced its vTv Therapeutics (VTVT) stake by 8.8% in Q2 2026, selling an estimated $3.43K and leaving 1,020 shares worth $38.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5665.

Osaic Holdings first reported a position in VTVT in Q1 2020 and has held it in 26 quarters since. The position peaked at $44.8K in Q4 2025. 45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Osaic Holdings held 1,020 shares of vTv Therapeutics worth $38.4K as of Q2 2026.
  • Osaic Holdings sold 99 vTv Therapeutics shares in Q2 2026, an estimated $3.43K.
  • vTv Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5665 holding.
  • Osaic Holdings first reported a position in vTv Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's vTv Therapeutics position peaked at $44.8K in Q4 2025.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.